» Articles » PMID: 25697868

Heart-specific Overexpression of (pro)renin Receptor Induces Atrial Fibrillation in Mice

Overview
Journal Int J Cardiol
Publisher Elsevier
Date 2015 Feb 21
PMID 25697868
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Atrial fibrillation (AF) is the most common cardiac arrhythmia, causing substantial cardiovascular morbidity and mortality. The renin-angiotensin system (RAS) has been shown to be involved in the pathophysiology of AF. The (pro)renin receptor [(p)RR] is the last identified member of RAS. However, the role of (p)RR in AF is still unknown.

Methods And Results: Circulating levels of (p)RR were determined using an immunosorbent assay in 22 patients with AF (paroxysmal or persistent) and 22 healthy individuals. The plasma levels of (p)RR increased 3.6-fold in AF patients (P<0.001), indicating a relationship between (p)RR and AF. To investigate the role of (p)RR in the regulation of cardiac arrhythmia, we generated a transgenic mouse with overexpression of human (p)RR gene specifically in the heart. Electrocardiograms from (p)RR transgenic mice showed typical atrial flutter since 2 months, then spontaneously converted to atrial fibrillation by 10 months. The atria of the transgenic mice demonstrated significant dilation and fibrosis, and exhibited a high incidence of sudden death. Additionally, the genes of SERCA and HCN4, which are involved in the electrophysiology of AF, were significantly down-regulated and up-regulated respectively in transgenic mice atria. The phosphorylation of Erk1/2 significantly increased in the atria of the transgenic mice, and the activated Erk1/2 was found predominantly in cardiac fibroblasts, suggesting that the transgenic (p)RR gene may induce atrial fibrillation by activation of Erk1/2 in the cardiac fibroblasts of the atria.

Conclusions: (p)RR promotes atrial structural and electrical remodeling in vivo, which indicates that (p)RR plays an important role in the pathological development of AF.

Citing Articles

Aliskiren-Loaded Nanoparticles Downregulate (Pro)renin Receptor and ACE Gene Expression in the Heart of Spontaneously Hypertensive Rats: Effect on NADPH Oxidase.

Barta A, Cebova M, Kovac A, Koneracka M, Zavisova V, Pechanova O Int J Mol Sci. 2024; 25(2).

PMID: 38255922 PMC: 10815459. DOI: 10.3390/ijms25020846.


The (pro)renin receptor as a pharmacological target in cardiorenal diseaes.

Funke-Kaiser H, Unger T Hypertens Res. 2023; 46(11):2527-2534.

PMID: 37667044 DOI: 10.1038/s41440-023-01424-6.


The role of (pro)renin receptor and its soluble form in cardiovascular diseases.

Wang B, Jie H, Wang S, Dong B, Zou Y Front Cardiovasc Med. 2023; 10:1086603.

PMID: 36824459 PMC: 9941963. DOI: 10.3389/fcvm.2023.1086603.


Inhibition of (Pro)renin Receptor-Mediated Oxidative Stress Alleviates Doxorubicin-Induced Heart Failure.

Du X, Xiang D, Gao P, Peng H, Liu Y Front Oncol. 2022; 12:874852.

PMID: 35574363 PMC: 9106363. DOI: 10.3389/fonc.2022.874852.


ATP6AP2 knockdown in cardiomyocyte deteriorates heart function via compromising autophagic flux and NLRP3 inflammasome activation.

Li L, Cui Y, Liu Y, Li H, Su Y, Li S Cell Death Discov. 2022; 8(1):161.

PMID: 35379787 PMC: 8980069. DOI: 10.1038/s41420-022-00967-w.